id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-2732-0021,FDA,FDA-2018-N-2732,Reference 2 -  Peptides Encoded by Short ORFs Control Development and Define a New Eukaryotic Gene Family,Supporting & Related Material,Background Material,2020-03-23T04:00:00Z,2020,3,,,2020-03-23T13:02:22Z,,0,0,0900006484398aef
FDA-2018-N-2732-0022,FDA,FDA-2018-N-2732,"Reference 3 FDA - Regulatory Impact Analysis, “Definition of the Term `Biological Product""",Supporting & Related Material,Background Material,2020-03-23T04:00:00Z,2020,3,,,2020-03-23T13:05:53Z,,0,0,090000648445f717
FDA-2018-N-2732-0019,FDA,FDA-2018-N-2732,Definition of the Term ‘‘Biological Product’’,Rule,Final Rule,2020-02-21T05:00:00Z,2020,2,2020-02-21T05:00:00Z,,2020-02-21T14:57:17Z,2020-03505,0,0,0900006484397e14
FDA-2018-N-2732-0020,FDA,FDA-2018-N-2732,Reference 1 - Small Proteins Untapped Area of Potential Biological Importance re: Definition of the Term ‘‘Biological Product’’,Supporting & Related Material,Background Material,2020-02-21T05:00:00Z,2020,2,,,2020-02-24T18:35:42Z,,0,0,0900006484398aee